Outcome of Crizotinib Treatment in a Young Woman with Heavily Pretreated ROS1-positive Lung Cancer

MLA

Petreni, Paolo, et al. “Outcome of Crizotinib Treatment in a Young Woman with Heavily Pretreated ROS1-Positive Lung Cancer.” Tumori Journal, vol. 101, no. 3, May 2015, pp. e103–06. EBSCOhost, https://doi.org/10.5301/tj.5000288.

APA

Petreni, P., Mazzoni, F., Meoni, G., Lunghi, A., Cecere, F. L., Muto, A., & Di Costanzo, F. (2015). Outcome of Crizotinib Treatment in a Young Woman with Heavily Pretreated ROS1-positive Lung Cancer. Tumori Journal, 101(3), e103–e106. https://doi.org/10.5301/tj.5000288

Chicago

Petreni, Paolo, Francesca Mazzoni, Giulia Meoni, Alice Lunghi, Fabiana Letizia Cecere, Andrea Muto, and Francesco Di Costanzo. 2015. “Outcome of Crizotinib Treatment in a Young Woman with Heavily Pretreated ROS1-Positive Lung Cancer.” Tumori Journal 101 (3): e103–6. doi:10.5301/tj.5000288.